WLKP · Westlake Chemical Partners LP
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Coverage ratio non-GAAP | 1.04 | Q2 2026 | — |
|
|
|||
| Quarterly distribution per unit | $0.47 | Q2 2026 | — |
|
|
|||
| MLP distributable cash flow non-GAAP | $17.9M | Q1 2026 | — |
| Quarterly coverage ratio non-GAAP | 1.08 | Q1 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WLKP
this stock
Westlake Chemical Partners LP
|
$777.52M | +14.2% | +2.7% | — | 0.3% |
|
SHECF
Shin-Etsu Chemical Co., Ltd.
|
$77.69B | +20.7% | — | — | 0.2% |
|
DOW
Dow Inc.
|
$22.39B | +32.9% | -7.0% | — | 4.9% |
|
NPXYY
Nippon Sanso Holdings Corporation/ADR
|
$16.69B | +29.8% | — | — | 0.0% |
|
CE
Celanese Corp
|
$5.01B | +8.0% | -7.1% | — | 7.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WLKP | +0.2% | -1.4% | +2.2% | +0.3% | +14.2% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -0.2% | -5.9% | -11.6% | -3.6% | +0.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.